Lazard’s Global Co-Heads of Biopharma, Dale Raine and Michael Kingston, Appear on The BioCentury Show

On October 17, Lazard’s Global Co-Heads of Biopharma, Dale Raine and Michael Kingston, were guests on an episode of The BioCentury Show, a podcast series that features in-depth conversations with global leaders in the biopharma industry.

During the episode, Dale and Michael, who co-lead Lazard’s European and North American healthcare teams respectively, discuss with host Simone Fishburn the trends shaping the deal and financing landscape for biopharma companies in their markets. Dale and Michael describe a market in 2024 dominated by smaller-sized clinical-stage transactions, evenly split between the public and private markets. With more acquisitions happening earlier, and at a quickening pace. They discuss how the transaction landscape is evolving and the degree to which biotech companies are embracing risk in their decision-making.

Click here to listen to the full episode.